Catalio Capital Management is a Venture capital investments in breakthrough biomedical technology companies.
Catalio Capital Management is a Venture capital investments in breakthrough biomedical technology companies.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 29, 2022
Medical Informatics
|
Series B | $17M | Health Care | Yes |
Nov 29, 2022
Medical Informatics
|
Series B | $17M | Health Care | Yes |
Nov 16, 2022
Haystack Oncology
|
Series A | $56M | Biotechnology | Yes |
Jul 13, 2022
Xilis
|
Series A | $19M | Biotechnology | — |
Mar 8, 2022
Sherlock Biosciences
|
Series B | $80M | Biotechnology | — |